Immix Biopharma, Inc. (IMMX): Cash & Equivalents
$93.93M
As of 2025-12-31
$225.49M
As of 2026-06-30
+91.2%
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $93.93M | +431.2% | 2026-03-27, Balance as of period end |
| 2024-12-31 | $17.68M | +1.0% | 2026-03-27, Balance as of period end |
| 2023-12-31 | $17.51M | +30.3% | 2025-03-25, Balance as of period end |
| 2022-12-31 | $13.44M | -23.8% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $17.64M | n/m | 2023-03-27, Balance as of period end |
| 2020-12-31 | $391.1K | n/a | 2022-03-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | 2025-12-31 | $93.93M | +431.2% |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | $26.31M | -15.0% |
| Tenax Therapeutics, Inc. (TENX) | 2025-12-31 | $97.60M | +2.8% |
| Celularity Inc (CELU) | 2025-12-31 | $6.17M | +736.7% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $60.54M | -3.1% |
| iBio, Inc. (IBIO) | 2026-06-30 | $56.40M | +557.1% |
| Minerva Neurosciences, Inc. (NERV) | 2025-12-31 | $82.30M | +285.3% |
| Rezolute, Inc. (RZLT) | 2026-06-30 | $10.62M | -88.7% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $21.82M | -60.8% |
Compare IMMX, AYTU, TENX, CELU side by side · Screen every company in Pharmaceutical Preparations ↗